Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for ICLR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 16.40B
March 31, 2026 16.32B
December 31, 2025 16.27B
September 30, 2025 16.16B
June 30, 2025 16.54B
March 31, 2025 16.72B
December 31, 2024 16.63B
September 30, 2024 16.98B
June 30, 2024 16.77B
March 31, 2024 16.85B
December 31, 2023 16.99B
September 30, 2023 17.03B
June 30, 2023 17.11B
March 31, 2023 17.29B
December 31, 2022 17.19B
September 30, 2022 17.13B
June 30, 2022 17.04B
March 31, 2022 17.16B
December 31, 2021 17.39B
September 30, 2021 17.65B
June 30, 2021 3.584B
March 31, 2021 3.467B
December 31, 2020 3.436B
September 30, 2020 3.065B
June 30, 2020 2.859B
Date Value
March 31, 2020 2.841B
December 31, 2019 2.908B
September 30, 2019 2.745B
June 30, 2019 2.719B
March 31, 2019 2.607B
December 31, 2018 2.354B
September 30, 2018 2.326B
June 30, 2018 2.174B
March 31, 2018 2.219B
December 31, 2017 2.147B
September 30, 2017 2.053B
June 30, 2017 1.904B
March 31, 2017 1.855B
December 31, 2016 1.826B
September 30, 2016 1.900B
June 30, 2016 1.750B
March 31, 2016 1.796B
December 31, 2015 1.719B
September 30, 2015 1.813B
June 30, 2015 1.636B
March 31, 2015 1.605B
December 31, 2014 1.529B
September 30, 2014 1.573B
June 30, 2014 1.526B
March 31, 2014 1.485B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
IQVIA Holdings, Inc. 29.88B
Medpace Holdings, Inc. 2.057B
Proteome Sciences Plc --
Champions Oncology, Inc. 26.99M
Avantor, Inc. 11.60B

Total Assets (Quarterly) Related Metrics